These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9643625)

  • 1. Variability in trough plasma saquinavir concentrations in HIV patients--a case for therapeutic drug monitoring.
    Barry MG; Merry C; Lloyd J; Halifax K; Carey P; Mulcahy F; Back DJ
    Br J Clin Pharmacol; 1998 May; 45(5):501-2. PubMed ID: 9643625
    [No Abstract]   [Full Text] [Related]  

  • 2. Single daily doses of saquinavir achieve HIV-inhibitory concentrations when combined with baby-dose ritonavir.
    Kurowski M; Müller M; Donath F; Mrozikiewicz M; Möcklinghoff C
    Eur J Med Res; 1999 Mar; 4(3):101-4. PubMed ID: 10085276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interaction between saquinavir and cyclosporine.
    Brinkman K; Huysmans F; Burger DM
    Ann Intern Med; 1998 Dec; 129(11):914-5. PubMed ID: 9867740
    [No Abstract]   [Full Text] [Related]  

  • 4. Garlic supplements found to lower saquinavir levels.
    TreatmentUpdate; 2001; 12(12):17-8. PubMed ID: 11570085
    [No Abstract]   [Full Text] [Related]  

  • 5. Reducing the boosting dose of ritonavir does not affect saquinavir plasma concentrations in HIV-1-infected individuals.
    van der Lugt J; Gorowara M; Avihingsanon A; Burger D; Ananworanich J; Sringam K; Kerr S; Wit F; Lange J; Ruxrungtham K
    AIDS; 2009 Jun; 23(9):1176-9. PubMed ID: 19451794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence-based therapeutic drug monitoring for saquinavir].
    Muret P; Solas C;
    Therapie; 2011; 66(3):207-12. PubMed ID: 21819804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-trimoxazole administered for Pneumocystis carinii pneumonia prophylaxis does not interfere with saquinavir pharmacokinetics.
    Maserati R; Villani P; Cocchi L; Regazzi MB
    AIDS; 1998 May; 12(7):815-6. PubMed ID: 9619815
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic study of saquinavir 500 mg plus ritonavir (1000/100 mg twice a day) in HIV-positive pregnant women.
    Martinez-Rebollar M; Lonca M; Perez I; Soy D; Brunet M; Martin R; Coll O; Hernandez S; Laguno M; Milinkovic A; Larrousse M; Calvo M; Blanco JL; Martínez E; Gatell JM; Mallolas J
    Ther Drug Monit; 2011 Dec; 33(6):772-7. PubMed ID: 22105596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patients.
    Gieschke R; Fotteler B; Buss N; Steimer JL
    Clin Pharmacokinet; 1999 Jul; 37(1):75-86. PubMed ID: 10451784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir.
    Hsu A; Granneman GR; Cao G; Carothers L; el-Shourbagy T; Baroldi P; Erdman K; Brown F; Sun E; Leonard JM
    Clin Pharmacol Ther; 1998 Apr; 63(4):453-64. PubMed ID: 9585800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of once-daily saquinavir/ritonavir in HIV-infected subjects: comparison with the standard twice-daily regimen.
    Boffito M; Dickinson L; Hill A; Back D; Moyle G; Nelson M; Higgs C; Fletcher C; Mandalia S; Gazzard B; Pozniak A
    Antivir Ther; 2004 Jun; 9(3):423-9. PubMed ID: 15259905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saquinavir exposure in HIV-infected patients with chronic viral hepatitis.
    Moltó J; Llibre JM; Ribera E; Mínguez C; del Río JS; Pedrol E; Vallecillo G; Cedeño S; Valle M; Miranda C; Negredo E; Clotet B;
    J Antimicrob Chemother; 2009 May; 63(5):992-7. PubMed ID: 19279052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
    Bittner B; Riek M; Holmes B; Grange S
    Antivir Ther; 2005; 10(7):803-10. PubMed ID: 16312177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and cerebrospinal fluid saquinavir concentrations in patients receiving combination antiretroviral therapy.
    Moyle GJ; Sadler M; Buss N
    Clin Infect Dis; 1999 Feb; 28(2):403-4. PubMed ID: 10064262
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study.
    Yilmaz A; Fuchs D; Hagberg L; Nillroth U; Ståhle L; Svensson JO; Gisslén M
    BMC Infect Dis; 2006 Mar; 6():63. PubMed ID: 16566834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interaction between darunavir and saquinavir in HIV-negative volunteers.
    Sekar VJ; Lefebvre E; Mariën K; De Pauw M; Vangeneugden T; Hoetelmans RM
    Ther Drug Monit; 2007 Dec; 29(6):795-801. PubMed ID: 18043478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy.
    Reiser M; Salzberger B; Stiepel A; Hoetelmans R; Diehl V; Fätkenheuer G
    Eur J Med Res; 1999 Feb; 4(2):54-8. PubMed ID: 10066640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals.
    Dickinson L; Boffito M; Back DJ; Khoo SH; Pozniak AL; Mugyenyi P; Merry C; Autar RS; Burger DM; Aarons LJ
    J Antimicrob Chemother; 2008 Dec; 62(6):1344-55. PubMed ID: 18824460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical guidelines to interpret plasma concentrations of antiretroviral drugs.
    Kappelhoff BS; Crommentuyn KM; de Maat MM; Mulder JW; Huitema AD; Beijnen JH
    Clin Pharmacokinet; 2004; 43(13):845-53. PubMed ID: 15509183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.